Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

ObsEva SA (company was delisted NASDAQ) (OBSV)

  • Event
  • June 28, 2022, 20:13 UTC
  • 10
  • 1 comments

(70% Positive) ObsEva SA (company was delisted NASDAQ) (OBSV) Announces Regulatory Update (Form 6-K)

Comment Full text

Achilles Therapeutics plc (ACHL)

  • Event
  • June 28, 2022, 20:03 UTC
  • 10
  • 1 comments

(99% Neutral) Achilles Therapeutics plc (ACHL) Announces 2021 Annual General Meeting

Comment Full text

Sanofi (SNY)

  • Event
  • June 28, 2022, 19:59 UTC
  • 10
  • 1 comments

(90% Positive) Sanofi (SNY) Announces Regulatory Update (Form 6-K)

Comment Full text

CureVac (CVAC)

  • Event
  • June 27, 2022, 20:16 UTC
  • 10
  • 1 comments

(99% Neutral) CureVac (CVAC) Files Form 6-K

Comment Full text

Genmab (GMAB)

  • Event
  • June 27, 2022, 14:24 UTC
  • 10
  • 1 comments

(99% Neutral) Genmab (GMAB) Files Form 6-K

Comment Full text

AstraZeneca (AZN)

  • Event
  • June 27, 2022, 11:57 UTC
  • 10
  • 1 comments

(10% Negative) AstraZeneca (AZN) Announces Clinical Development Update (Form 6-K)

Comment Full text

AstraZeneca (AZN)

  • Event
  • June 27, 2022, 11:44 UTC
  • 10
  • 1 comments

(85% Positive) AstraZeneca (AZN) Announces Clinical Development Update (Form 6-K)

Comment Full text

BioNTech SE (BNTX)

  • Event
  • June 27, 2022, 11:25 UTC
  • 10
  • 1 comments

(80% Positive) BioNTech SE (BNTX) Announces Regulatory Update (Form 6-K)

Comment Full text

HUTCHMED DRC (HCM)

  • Event
  • June 27, 2022, 10:20 UTC
  • 10
  • 1 comments

(99% Neutral) HUTCHMED DRC (HCM) Files Form 6-K

Comment Full text

BioNTech SE (BNTX)

  • Event
  • June 23, 2022, 20:34 UTC
  • 10
  • 1 comments

(90% Positive) BioNTech SE (BNTX) Announces Clinical Development Update (Form 6-K)

Comment Full text
  • Previous
  • 170
  • 171
  • 172
  • 173
  • 174
  • Next

Search

News categories

  • Technical Exchange News(10870)
  • Event(2243)
  • SEC News(189156)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124509)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin